1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)" is currently closed and not accepting applications.
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). This grant supports highly collaborative, multidisciplinary research teams. While not exclusively for vaccine development, NIH is a primary funder of vaccine research, and this mechanism can support complex, team-based projects relevant to vaccine development.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Collaborative Program Grant for Multidisciplinary Teams (RM1) | National Institute of General Medical Sciences Team science can achieve outcomes that may not be possible through the efforts of individual laboratories.
The NIGMS Collaborative Program Grant for Multidisciplinary Teams (RM1) supports applications from a highly integrated team of investigators addressing a single-focused, ambitious, and challenging project that cannot be addressed by individual R01 applications. The RM1 is a single application and not a collection of sub-projects. The proposed RM1 team must comprise of three to six principal investigators.
The research topic must be central to the NIGMS mission areas and projects should not be achievable by individual efforts. The RM1 program requires the participation of multiple investigators with complementary expertise to achieve the team's research objectives. Applications must have well-defined goals that can be achieved within 5-10 years.
The team of researchers can be located at a single institution or multiple institutions throughout the United States. A fully integrated team of investigators will have shared management responsibility. Teams have the option to request development funds in year 2-5 to add Early Stage Investigators with complementary expertise to the program.
For additional information on the NIGMS Collaborative Program Grant for Multidisciplinary Teams (RM1), please contact Oleg Barski, Ph. D. and Chi-Wing Chow, Ph.
D. at RM1mailbox@nigms. nih.
gov . For more information on the Biomedical Technology Optimization and Dissemination Centers (RM1), visit the BTOD page .
PAR-23-077 Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) FAQs About PAR-23-077 Collaborative Program Grant for Multidisciplinary Teams Webinar on Funding Announcements for Team Science and Biomedical Technology Development and Dissemination Centers Funded Research for Collaborative Teams RM1 Considerations for Multiple Principal Investigator (MPI) Applications Feedback Loop Posts on Team Science This page last updated on
According to the current listing, eligibility includes: Two applications per institution (with a Unique Entity Identifier and a unique NIH eRA Institutional Profile File (IPF) number) are allowed per review round. The same or a similar topic may be submitted for subsequent review rounds involving the same or a similar team, but must be presented as a New application, not a Resubmission. Confirm the full requirements in the official notice before applying.
The current listing shows not specified, but R01s (a common NIH grant type) average $139 million. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was January 1, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article